Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

NCT06608927 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

610

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Quemliclustat
DRUG: Placebo
DRUG: Nab-paclitaxel
DRUG: Gemcitabine

Sponsor

Arcus Biosciences, Inc.

Collaborators

[object Object]